Collaborate on innovative manufacturing technologies that accelerate the ability to bring life-saving and life-enhancing products to market
Help companies find ways to adopt and implement new technologies and approaches, enhancing patient access to medicines and vaccines
Cultivate a world-leading biopharmaceutical workforce through novel training and education programs
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
RFP 7.1 includes both technology development and workforce development topics, with a funding amount of up to $4 million. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Project Call 7.1 closed on December 7, 2023. Submissions are now in review.
RFI 2023.1 – Next-Generation Sequencing (NGS) Method Development Study – aims to promote collaboration among multiple laboratories and industry partners to enhance the reliability, consistency, and understanding of AAV vector properties using NGS-based analysis methods.
RFI 2023.1 Next-Generation Sequencing (NGS) Method Development Study closed on September 5, 2023.
Student applications are currently being accepted for the 2024 NIIMBL eXperience, a week-long program, designed to introduce Black, Latinx, and Indigenous college students to career possibilities in the biopharmaceutical industry. NIIMBL has awarded $370K to five program locations across the country.
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
RFP 7.1
RFP 7.1 includes both technology development and workforce development topics, with a funding amount of up to $4 million. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Project Call 7.1 closed on December 7, 2023. Submissions are now in review.
RFI 2023.1: Viral Vectors
RFI 2023.1 – Next-Generation Sequencing (NGS) Method Development Study – aims to promote collaboration among multiple laboratories and industry partners to enhance the reliability, consistency, and understanding of AAV vector properties using NGS-based analysis methods.
RFI 2023.1 Next-Generation Sequencing (NGS) Method Development Study closed on September 5, 2023.
RFA: NIIMBL eXperience
Student applications are currently being accepted for the 2024 NIIMBL eXperience, a week-long program, designed to introduce Black, Latinx, and Indigenous college students to career possibilities in the biopharmaceutical industry. NIIMBL has awarded $370K to five program locations across the country.
RFA: Faculty Fellows
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
Our membership is made up of a diverse set of stakeholders from across the biopharmaceutical manufacturing ecosystem.
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
No Data Found
June 30, 2023
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Biopharmaceuticals are medicines that save, sustain, and improve lives.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.